Chengdu, China – March 21, 2026 — MicroPort® MedBot™ and West China Hospital of Sichuan University announced the inauguration of the West China International Telesurgery Command Center alongside the successful completion of multiple intercontinental telesurgical procedures using the Toumai® laparoscopic surgical robotic system.

On the same day, surgical teams in China and Brazil completed three cross-regional procedures, including a Nissen fundoplication performed across an approximate distance of 18,000 kilometers with a total bidirectional communication distance of approximately 64,000 kilometers. The procedure was completed over conventional broadband infrastructure with stable system performance throughout. From network setup to completion, the entire process was accomplished within four days, demonstrating operational feasibility under real-world conditions.

Prof. Carlos Eduardo Domene, who performed the procedure from Brazil, commented:

"Although Brazil and Chengdu are nearly 18,000 kilometers apart, the ultra-high-definition, multi-angle imaging system provided exceptional visual clarity and realistic depth perception. The overall experience was stable and intuitive, enabling precise surgical performance."

The West China International Telesurgery Command Center is designed to support remote surgical procedures, multicenter clinical collaboration, surgical education, and research. It integrates clinical, academic, and training functions with 24-hour operational support.

Prof. Alex Mottrie noted that the significance of telesurgery extends beyond individual procedures by supporting greater collaboration between surgical teams across geographic boundaries.

The Toumai® surgical robotic system has been used in telesurgical procedures across multiple specialties, including urology, general surgery, thoracic surgery, gynecology, pediatric surgery, and cardiac surgery. MicroPort® MedBot™ continues to work with clinical partners to advance technologies supporting connected surgery and expand access to specialist surgical expertise worldwide.

About MicroPort® MedBot™

Commenced its development for laparoscopic surgical robots in 2014 and officially established in Shanghai in 2015, Shanghai MicroPort MedBot (Group) Co., Ltd. ("MicroPort® MedBot™", stock code: 02252.HK), a subsidiary of MicroPort Scientific Corporation ("MicroPort®", stock code: 00853.HK), is currently the only surgical robotics company with businesses spanning five major segments: laparoscopic, orthopedic, vascular interventional, natural orifice, and percutaneous surgical robotics.

MicroPort® MedBot™ is committed to meeting the growing demand for advanced robotic surgery by integrating robotics, intelligent control, image-guided navigation, and precision imaging technologies to provide comprehensive intelligent surgical solutions that advance minimally invasive care worldwide.

Regulatory Disclaimer

The Toumai® laparoscopic surgical robotic system's regulatory approvals and cleared indications vary by country and region. Not all indications or uses described in this release may be approved in all markets. Healthcare professionals should refer to applicable local regulatory requirements and the product instructions for use.